Multiply Labs has developed a robotic biomanufacturing cluster that the company claims can reduce the cost of cell and gene therapy (CGT) manufacturing by 74%. The modular system achieves this by ...
Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. "This is a quantum leap in ...
Multiply Labs collaborated with these life science industry leaders to demonstrate automated cell therapy manufacturing tasks, with an emphasis on cell expansion. The results of the proof-of-concept ...
Forbes contributors publish independent expert analyses and insights. I'm a senior tech contributor who writes about science and technology Multiply Labs and Universal Robots have entered a ...
Portal Biotechnologies and Multiply Labs announced a collaboration with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more ...
Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results